首页> 外文会议>International conference on membrane science and technology >Removal of Bacteriophase phix174 From Protein Solutions Using Pvdf Ultrafiltration Membranes
【24h】

Removal of Bacteriophase phix174 From Protein Solutions Using Pvdf Ultrafiltration Membranes

机译:使用PVDF超滤膜从蛋白质溶液中除去噬菌体体pHIX174

获取原文

摘要

The production of therapeutic proteins, by extraction from human and animal tissue and fluids and from continuously cultrued mammalian cells, ahs associated with it the risk of potential contamination by viruses. Viral contamination is a major problem, as current echniques for both the detection and the inactivation/removal of viruses leave much to be desired. Not all viruses are known and detected easily. New types f viruses or virus-like particles appear now and then. The current methods for virus inactivation, such as chemical, thermal, ultraviolet, and gamma-ray treatment, do not affect all viruses equally. The non enveloped viruses have proved ot be more resistant to the inactivation treatment, Also, as these physical and chemical methods allow the inactivated virus to remain within the product, recombinant incorporation of viral DNA/RNA is a concern (DiLeo et al 1992). With some techniques, protein stabilisation is required and any virucidal and/or stabilishing chemicals introduced during the process must the redced to safe levels n the final products.
机译:通过从人和动物组织和流体和来自连续尖锐的哺乳动物细胞中提取的治疗性蛋白质的产生,AHS与病毒潜在污染的风险相关。病毒污染是一个主要问题,因为检测和灭活/去除病毒的电流Echniques留下了许多需要。并非所有病毒都是已知的并且容易检测到。新类型F病毒或病毒样粒子现在然后出现。目前用于病毒失活的方法,例如化学,热,紫外线和γ射线处理,不会平等地影响所有病毒。由于这些物理和化学方法允许灭活病毒留在产物内,因此不包裹的病毒已经证明了OT更耐受抗动性治疗,因此重组掺入病毒DNA / RNA是一个问题(Dileo等,1992)。通过一些技术,需要蛋白质稳定化,并且在该过程中引入的任何植生和/或稳定化学物质必须转录到安全水平的最终产品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号